SenesTech, Inc. Common Stock
SNESSenesTech, Inc. (SNES) is a biotechnology company that develops and commercializes products aimed at managing pest populations through reproductive control. The company is best known for its innovative use of reproductive suppression technology to address pest-related challenges in agriculture, urban settings, and beyond. Its flagship product, ContraPest, is designed to effectively reduce rodent populations by targeting their fertility, offering an environmentally friendly and humane alternative to traditional pest control methods.
Company News
SenesTech reported record quarterly revenue of $690,000, a 43% increase from the previous year, with Evolve® Rodent Birth Control product sales growing 77% and representing 85% of total revenue. The company continues to expand across e-commerce, municipal, and retail markets while maintaining a strong cash balance of $10.2 million.
The California Department of Pesticide Regulation has awarded a grant to launch the Effective Urban Rodent Ecology Knowledge Alliance (EUREKA) project, which aims to revolutionize urban rat control through smart technology and community-based solutions while eliminating the need for harmful rodenticides.
SenesTech, Inc. (NASDAQ: SNES), a company specializing in fertility control for animal pest populations, has announced a 1-for-10 reverse stock split effective July 25, 2024. The company reported a 78% surge in Q1 2024 revenue but also a net loss of $1.8 million.
SenesTech (SNES) looks to leverage the convenience and reach of e-commerce to expand its market share.
Penny stocks to buy? 4 to watch before 2024 The post Top Penny Stocks For 2024? 4 For Your Watch List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
